Literature DB >> 11696545

Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein.

Bradley Saville1, Hetti Poukka, Mark Wormke, Olli A Janne, Jorma J Palvimo, Matthew Stoner, Ismael Samudio, Stephen Safe.   

Abstract

SNURF is a small RING finger protein that binds the zinc finger region of steroid hormone receptors and enhances Sp1- and androgen receptor-mediated transcription in COS and CV-1 cells. In this study, we show that SNURF coactivates both wild-type estrogen receptor alpha (ERalpha) (4-fold)- and HE19 (ERalpha deletion of activation function 1 (AF1)) (210-fold)-mediated activation of an estrogen-responsive element promoter in ZR-75 cells. In mammalian two-hybrid assays in ZR-75 cells SNURF interactions were estrogen (E2)-dependent and were not observed with the antiestrogen ICI 182,780. ERalpha interacted with multiple regions of SNURF; SNURF interactions with ERalpha were dependent on AF2, and D538N, E542Q, and D545N mutations in helix 12 abrogated both SNURF-ERalpha binding and coactivation. Moreover, peptide fusion proteins that inhibit interactions between helix 12 of ERalpha with LXXLL box-containing proteins also blocked ERalpha coactivation by SNURF. However, cotransfection of SNURF with prototypical steroid receptor coactivators 1, 2, and 3 that contain LXXLL box motifs did not enhance E2 responsiveness, whereas TATA-binding protein (TBP) and SNURF cooperatively coactivated ERalpha-mediated transactivation. The results are consistent with a unique model for cooperative coactivation of ERalpha that requires ligand binding, repositioning of helix 12, recruitment of TBP, and interaction with SNURF, which binds both ERalpha and TBP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696545     DOI: 10.1074/jbc.M109021200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells.

Authors:  Rhone A Mendoza; Marlene I Enriquez; Sylvia M Mejia; Emily E Moody; Gudmundur Thordarson
Journal:  J Endocrinol       Date:  2010-10-25       Impact factor: 4.286

2.  SPBP is a phosphoserine-specific repressor of estrogen receptor alpha.

Authors:  Valentina Gburcik; Nathalie Bot; Marcello Maggiolini; Didier Picard
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 3.  Ubiquitylation of nuclear receptors: new linkages and therapeutic implications.

Authors:  Kyle T Helzer; Christopher Hooper; Shigeki Miyamoto; Elaine T Alarid
Journal:  J Mol Endocrinol       Date:  2015-05-05       Impact factor: 5.098

4.  Cross talk in hormonally regulated gene transcription through induction of estrogen receptor ubiquitylation.

Authors:  Min Luo; Mingshi Koh; Jiajun Feng; Qiang Wu; Philippa Melamed
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

5.  Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.

Authors:  Susan M Dougherty; Williard Mazhawidza; Aimee R Bohn; Krista A Robinson; Kathleen A Mattingly; Kristy A Blankenship; Mary O Huff; William G McGregor; Carolyn M Klinge
Journal:  Endocr Relat Cancer       Date:  2006-03       Impact factor: 5.678

Review 6.  Genome stability roles of SUMO-targeted ubiquitin ligases.

Authors:  J Heideker; J J P Perry; M N Boddy
Journal:  DNA Repair (Amst)       Date:  2009-02-23

7.  Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.

Authors:  Francesca Orso; Erika Cottone; Mark D Hasleton; J Claire Ibbitt; Piero Sismondi; Helen C Hurst; Michele De Bortoli
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

8.  Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain.

Authors:  John R Hawse; Malayannan Subramaniam; David G Monroe; Amanda H Hemmingsen; James N Ingle; Sundeep Khosla; Merry Jo Oursler; Thomas C Spelsberg
Journal:  Mol Endocrinol       Date:  2008-05-15

Review 9.  STUbLs in chromatin and genome stability.

Authors:  Renee Garza; Lorraine Pillus
Journal:  Biopolymers       Date:  2013-02       Impact factor: 2.505

Review 10.  Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy.

Authors:  Wenlin Shao; Myles Brown
Journal:  Breast Cancer Res       Date:  2003-11-07       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.